Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an oral prodrug of allopregnanolone that is being studied for major depressive ...
It has been a busy week for psychedelic medicines developer Cybin, marked by a breakthrough designation (BTD) from the FDA for its depression ... current antidepressant drugs – were in remission ...
Sep. 6, 2024 — Serotonin in depression is highly relevant in diagnosis, treatment, and drug development. To better study this area, a team has now developed a fluorescent probe for imaging ...